Soluble c-erbB-2 fragment in serum correlates with disease stage and predicts for shortened survival in patients with early-stage and advanced breast cancer
about
HER-2 gene amplification can be acquired as breast cancer progressesChallenges in the clinical utility of the serum test for HER2 ECDHER2 testing: a review of detection methodologies and their clinical performanceSerum HER2 level measured by dot blot: a valid and inexpensive assay for monitoring breast cancer progression.Targeted therapy in breast cancer: the HER-2/neu gene and protein.The Therapeutic Challenge of Targeting HER2 in Endometrial CancerSoluble ectodomain of c-erbB-2 oncoprotein in relation to tumour stage and grade in human renal cell carcinomaNon-invasive, ultra-sensitive, high-throughput assays to quantify rare biomarkers in the blood.Evaluation of HER2/neu oncoprotein in serum & tissue samples of women with breast cancer.Serum HER2 levels determined by two methods in patients with metastatic breast cancer.Surface plasmon resonance investigations of human epidermal growth factor receptor 2.A sensitive and high-throughput assay to detect low-abundance proteins in serum.Truncated ErbB2 receptor (p95ErbB2) is regulated by heregulin through heterodimer formation with ErbB3 yet remains sensitive to the dual EGFR/ErbB2 kinase inhibitor GW572016.Prognostic and predictive impact of the HER-2/ neu extracellular domain (ECD) in the serum of patients treated with chemotherapy for metastatic breast cancer.ErbB-2 protein levels in healthy, asymptomatic women.The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy.Serum HER-2 concentrations for monitoring women with breast cancer in a routine oncology setting.
P2860
Q24563115-02F088DB-6F01-4FFA-BAAC-808E2FFF9A6DQ26861754-53DED5CA-DE62-46F6-AB0F-C6289AE87967Q28280488-B9DB2B37-75E2-4F6C-8974-B140C6FD1A52Q33886818-7012E120-583C-45AD-A9BD-C5A3F39A4985Q35648508-0104439F-54A0-44F5-ADDD-E1453E6E101BQ36064912-05ECD895-A3AC-4B83-9CF1-8AC46FE0E8C8Q36421735-7510458D-0EAC-4381-8975-3CF19681F06AQ37020386-76C26BA1-6C85-4916-9AAF-E5BE6B4FFBC2Q37367705-EECAD9BB-C680-4E08-B706-424FF391EDE3Q37386272-DB666FE4-127A-460F-8A03-C5B7547B017AQ40227424-2B06F821-C985-4174-B687-BED07D073449Q40305932-87817D1C-FC0F-4BF8-A63B-C97E7EBC5E06Q40596817-8E5AEE12-D46C-460F-8CA3-32656C5CADA1Q44952288-BFCA2F5D-1DAA-4590-8B77-21F04D5F115CQ47735351-8A3DFBBA-C29F-45EC-9AF7-E95DE1F41E9DQ54115075-2BD8C23B-A946-4B74-83EB-AC27BB4A75F6Q54722626-801EDC2D-CA76-457F-B452-349B7AD58830
P2860
Soluble c-erbB-2 fragment in serum correlates with disease stage and predicts for shortened survival in patients with early-stage and advanced breast cancer
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Soluble c-erbB-2 fragment in s ...... age and advanced breast cancer
@ast
Soluble c-erbB-2 fragment in s ...... age and advanced breast cancer
@en
type
label
Soluble c-erbB-2 fragment in s ...... age and advanced breast cancer
@ast
Soluble c-erbB-2 fragment in s ...... age and advanced breast cancer
@en
prefLabel
Soluble c-erbB-2 fragment in s ...... age and advanced breast cancer
@ast
Soluble c-erbB-2 fragment in s ...... age and advanced breast cancer
@en
P2093
P2860
P356
P1476
Soluble c-erbB-2 fragment in s ...... age and advanced breast cancer
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1994.387
P407
P577
1994-10-01T00:00:00Z